Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

RUNAWAY BAY, Jamaica, June 13, 2025 (GLOBE NEWSWIRE) -- Rose Hill Apothecary ("The Company" or "Rose Hill"), a global leader in the research and intellectual property of premium psilocybin products, today announced the successful execution of its first major international export agreement, marking a significant milestone in the global advancement of regulated psychedelic medicine. The company has exported 18 kilograms of dried, psilocybin-containing mushrooms to Biocase Brasil Importação e Comércio de Medicamentos Ltda (Biocase Brasil) for use in medicinal research and development initiatives under Brazil's regulatory framework.

All exported materials meet stringent Certificate of Analysis (COA) standards, with comprehensive testing conducted by ACS Laboratory in Florida. Tests covered potency, heavy metals, pesticides, and microbiological safety, underscoring Rose Hill's commitment to quality and compliance in the emerging psychedelics sector.

"This landmark agreement is a testament ...